NCT05824039 is a NA clinical trial of Tea infusion in Overweight, sponsored by Laouani Aicha.

Who is sponsoring NCT05824039?

NCT05824039 is sponsored by Laouani Aicha.

What drugs are being tested in NCT05824039?

Interventions in NCT05824039: Tea infusion.

What condition does NCT05824039 study?

NCT05824039 studies Overweight, Obesity.

Is NCT05824039 still recruiting?

NCT05824039 is currently completed. Last updated 25 April 2023.

Last reviewed 2023-04-25 · How we verify

NCT05824039

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Efficacy of Medicinal Plant Extract in Overweight and Obese Participants.

Completed NA Last updated 25 April 2023

What this trial tests

NA trial testing Tea infusion in Overweight in 98 participants. Completed in 8 April 2022.

Timeline

20 March 2021

Primary endpoint
8 April 2022

8 April 2022

Quick facts

Lead sponsor	Laouani Aicha
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	98
Start date	20 March 2021
Primary completion	8 April 2022
Estimated completion	8 April 2022
Sites	1 location across Tunisia

Drugs / interventions tested

Tea infusion

Conditions studied

Overweight — all drugs for Overweight →
Obesity — all drugs for Obesity →

Sponsor

Laouani Aicha

Who can join

Adults 18 to 75, any sex, with Overweight or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized , double -blind clinical trial is to evaluate the efficacy and safety of a daily administration of Nitraria retusa extract in overweight and obese participants, during 10 days.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Tea infusion

Trials testing the same drug.

NCT05406960 — Therapeutic Effect of Herbal Infusion on Menometrorrhagia · NA · completed

Other recruiting trials for Overweight

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05824039 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laouani Aicha
Last refreshed: 25 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05824039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing